Read Trump's announcement closely and ask what it contains. There is no text, no schedule, no enforcement mechanism and no vote. There is a claim, delivered by the president, that Thailand will wipe out tariffs on American goods and dismantle "major non-tariff barriers" on cars, medical equipment, pharmaceuticals and ethanol. Thailand's prime minister, more cautiously, says work remains. That is not a trade agreement. It is a press release with a country attached.
The list of beneficiaries is the story. Automakers, device makers, drug companies and ethanol producers are the industries that get named. Workers are absent, along with wages, labor rights, environmental standards and consumers. For decades, the Left attacked NAFTA and the Trans-Pacific Partnership for being written by corporate lobbyists. We were told that was the old globalism. Trump's version drops even the pretense of side chapters on labor and the environment and keeps the part where corporate wish lists become national policy.
Consider "non-tariff barriers" on pharmaceuticals and medical equipment. That phrase can mean pointless red tape. It can also mean a country's drug-pricing rules, safety reviews, procurement preferences and patent flexibilities. Thailand has a history here. In the mid-2000s it issued compulsory licenses for HIV and heart medications so patients could afford them, and it drew American pressure for doing so. It also runs a universal health coverage system that covers most of the population and is the envy of much of the developing world. Washington is a poor messenger for that fight. The United States spends more on health care than any other country and still leaves millions uninsured, in large part because we let the drug industry set its own prices. Exporting that arrangement is no gift to Thai patients.
Then there is the $2.6 billion in agricultural purchases. In a country that exports tens of billions of dollars of goods to the United States each year, it is a rounding error with a ribbon on it. But it fits the pattern: a big number, a vague timetable, and a farm-state audience. If Thai markets open further to American ethanol and farm goods, the Thai farmers and cane growers who compete with them will absorb the cost. A Left that talks about solidarity with workers cannot shrug at that because the victims live in Isan rather than Iowa.
The usual conservative defense is that Trump is finally forcing open closed markets, and some barriers are indeed protectionist. That is fair as far as it goes. But it misses the central fact. American consumers are still paying Trump's own tariffs, including a 19 percent rate on Thai goods. Thailand is being asked to go to zero, while Americans keep paying a tax on imports that the president claims is a gift from foreigners. That is not free trade. It is a toll booth with a trade-policy slogan on it.
The context also matters. Thailand was negotiating with the threat of much higher tariffs hanging over it, and Trump had already shown, during last summer's Thai-Cambodian border fighting, that he treats market access as a personal bargaining chip for unrelated disputes. Deals made at that level of coercion are not agreements between equals. They are tribute, and the terms are set by whoever has the biggest market and the shortest temper.
Democrats should be careful, too. Defending the old trade order will not persuade the voters it left behind, and the answer to Trump is not nostalgia. The answer is to demand what trade deals have always needed and never reliably got: published text, congressional approval, enforceable labor and environmental standards, and public-health rules that cannot be bargained away to a pharmaceutical lobby. If this is a good deal, Trump can show us the paper. If he will not, the rest of us should assume the winners are the ones he named.
How it may affect me
If the deal is finalized, U.S. consumers will likely see little relief: Thai goods still face American tariffs, which importers often pass on in prices. The main winners are likely U.S. exporters of vehicles, medical devices, drugs and ethanol, along with some farm-state producers. Thai farmers and local manufacturers may face tougher competition. Watch the published text for changes affecting drug pricing and access.


